医学
血脂异常
冠状动脉疾病
物理疗法
不利影响
疾病
内科学
风险因素
冲程(发动机)
他汀类
禁欲
心理干预
重症监护医学
精神科
机械工程
工程类
作者
Marios Arvanitis,Charles J. Lowenstein
标识
DOI:10.7326/aitc202306200
摘要
Dyslipidemia is an important risk factor for coronary artery disease and stroke. All persons with dyslipidemia should be advised to focus on lifestyle interventions, including regular aerobic exercise, a healthy diet, maintenance of a healthy weight, and abstinence from smoking. In addition to lifestyle interventions, lipid-lowering therapy should be considered for persons at moderate to high risk for atherosclerotic cardiovascular disease based on validated risk equations. Statin therapy is the first-line medical treatment for dyslipidemia due to its effectiveness and favorable adverse effect profile, but newer treatments provide additional tools for clinicians to effectively treat dyslipidemia.
科研通智能强力驱动
Strongly Powered by AbleSci AI